ホーム › 潰瘍性大腸炎 › イリノイ州 › Chicago
Chicago、ILにおける潰瘍性大腸炎の臨床試験
Chicagoとその周辺地域（約30マイル以内）の拠点で、潰瘍性大腸炎に関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
被験者募集中第3相
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- Northwestern University, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
被験者募集中第2相
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
被験者募集中第2相
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
被験者募集中第3相
- Rush University Medical Center, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
被験者募集中第2相
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
被験者募集中第2相
- Northwestern University, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
被験者募集中第4相
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
被験者募集中
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
被験者募集中観察研究
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
被験者募集中第2相
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
被験者募集中第2相
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
被験者募集中
- University of Chicago, Chicago
他の都市における潰瘍性大腸炎の試験
- New York City, NY24件の研究
- Orlando, FL23件の研究
- Miami, FL22件の研究
- Houston, TX18件の研究
- San Antonio, TX16件の研究
- Tacoma, WA15件の研究
- San Diego, CA15件の研究
- Colorado Springs, CO14件の研究
- St. Louis, MO14件の研究
- Tyler, TX14件の研究
- Los Angeles, CA13件の研究
- Boston, MA12件の研究
Chicagoにおける他の研究
- 非小細胞肺癌61件の研究
- 乳がん58件の研究
- がん（全種類）51件の研究
- 前立腺がん45件の研究
- 転移性癌45件の研究
- 肥満症42件の研究
- 肺がん41件の研究
- 卵巣がん36件の研究
- 脳卒中34件の研究
- 大腸癌32件の研究
- 心不全31件の研究
- 過体重28件の研究
ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。